Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.018 | 0.8 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |